AI screening for a heart condition called ATTR-CM
Part of Heart & circulation clinical trials.
This study uses artificial intelligence (AI) to look at your heart tests (ECG and echo) and find people who might have a specific heart muscle disease called ATTR-CM. The goal is to catch it earlier so treatment can start sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have had both an ECG (heart electrical test) and an echo (ultrasound of the heart) at Yale New Haven Health System.
- You must have a diagnosis of heart failure with preserved ejection fraction (HFpEF) or mildly reduced ejection fraction (HFmrEF).
- You must have been in the earlier Phase I TRACE-AI study, which included an AI check of your ECG and echo in the last 3 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to analyze heart tests (ECGs) to help diagnose and predict outcomes for people with heart disease. It may lead to better and faster detection of heart conditions.
This study tests whether artificial intelligence (AI) can analyze heart signals from a standard 12-lead ECG and a simpler 1-lead ECG. Participants will have an extra ECG taken during their regular visit, which takes just a few extra minutes and helps doctors learn if AI can spot heart issues from a simpler test.
This research study checks a small sample of heart tissue during pacemaker or defibrillator placement to see if amyloidosis, a condition where abnormal proteins build up in organs, is present. It aims to find amyloidosis earlier so treatment can start sooner.
This study tests whether an artificial intelligence (AI) tool can help find people who have undiagnosed heart valve problems by analyzing their electrocardiogram (ECG) results. If you visit the emergency room and have an ECG, the AI might help identify if you need further heart tests.
This study at Mayo Clinic is testing an artificial intelligence (AI) tool that analyzes echocardiograms (ultrasound of the heart) to find early signs of four types of heart muscle disease. If the AI flags a high-risk pattern, doctors can learn whether acting on that alert helps catch the condition sooner.
This trial tests an AI program that looks at your heart ultrasound (echocardiogram) to find possible signs of cardiac amyloidosis early. It helps doctors decide if more testing is needed.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.